Pre-earnings options volume in Edwards Lifesciences (EW) is 4.3x normal with calls leading puts 5:4. Implied volatility suggests the market is anticipating a move near 5.3%, or $4.11, after results are released. Median move over the past eight quarters is 3.7%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW:
- Notable companies reporting after market close
- These Are the Stocks Reporting Earnings Today – February 10, 2026
- Is EW a Buy, Before Earnings?
- Edwards Lifesciences price target lowered to $94 from $95 at UBS
- Edwards Lifesciences: Buy Rating Backed by Favorable TAVR Reimbursement Outlook and Asymptomatic Coverage Upside